Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
THERMO FISHER SCIENTIFIC INC. entered into Fifth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at €1,000,000,000 aggregate principal amount of Floating Rate Senior Notes due 2027 and €1,100,000,000 (effective 2025-12-01).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- The Bank of New York Mellon Trust Company, N.A.
- Value
- €1,000,000,000 aggregate principal amount of Floating Rate Senior Notes due 2027 and €1,100,000,000
- Effective
- 2025-12-01
Exact text from the filing
On December 1, 2025, Thermo Fisher Scientific (Finance I) B.V. (“Thermo Fisher International”), an indirect, wholly-owned finance subsidiary of Thermo Fisher Scientific Inc. (the “Company”), issued €1,000,000,000 aggregate principal amount of Floating Rate Senior Notes due 2027 (the “Floating Rate Notes”) and €1,100,000,000 aggregate principal amount of 3.628% Senior Notes due 2035 (the “Fixed Rate Notes” and, together with the Floating Rate Notes, the “Notes”) in a public offering (the “Offering”) pursuant to a registration statement on Form S-3ASR (File No. 333-285159) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Notes, each as previously filed with the Securities and Exchange Commission. The Company has fully and unconditionally guaranteed the Notes on a senior unsecured basis (the “Guarantees” and, together with the Notes, the “Securities”). The Securities were issued under an indenture, dated as of August 9, 2016 (the “Base Inden
View on SEC.gov